Yi-Qiang Liang Selected Research

Yi-Qiang Liang Research Topics

4	Stroke (Strokes) 01/2020 - 12/2003
2	Insulin Resistance 01/2012 - 04/2005
2	Essential Hypertension 10/2008 - 04/2008
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2022
1	Brain Ischemia (Cerebral Ischemia) 01/2020
1	Fatty Liver 01/2020
1	Atherosclerosis 01/2020
1	Lung Neoplasms (Lung Cancer) 07/2009
1	Large Cell Carcinoma 07/2009
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2009
1	Adenocarcinoma 07/2009
1	Hypertension (High Blood Pressure) 04/2008
1	Body Weight (Weight, Body) 03/2005

3	Glucose (Dextrose)FDA LinkGeneric 01/2012 - 12/2003
2	SaltsIBA 01/2020 - 03/2005
1	Antihypertensive Agents (Antihypertensives)IBA 01/2022
1	Cholesterol Ester Transfer ProteinsIBA 01/2020
1	oxidized low density lipoproteinIBA 01/2020
1	CholesterolIBA 01/2020
1	LipidsIBA 01/2020
1	HDL CholesterolIBA 01/2020
1	LDL CholesterolIBA 01/2020
1	Triglycerides (Triacylglycerol)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	MicroRNAs (MicroRNA)IBA 01/2020
1	LectinsIBA 01/2020
1	Class E Scavenger Receptors (Lectin Like Oxidized Low Density Lipoprotein Receptor 1)IBA 01/2020
1	lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA 07/2009
1	DNA (Deoxyribonucleic Acid)IBA 07/2009
1	DNA-Activated Protein KinaseIBA 07/2009
1	Angiotensin II Type 1 Receptor BlockersIBA 10/2008
1	candesartanIBA 10/2008
1	Atorvastatin (Lipitor)FDA Link 04/2008
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2008
1	Fatty Acids (Saturated Fatty Acids)IBA 04/2005